Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Ingevity CorporationNYSE: NGVT

Net Income · Q3 FY2026 · quarter ended Sep 2026

Net income grows, but more slowly than its trailing trend

Q3 FY2026 net income of $49.3M rose 13.3% year over year, behind the +190.7% change in trailing-twelve-month net income. Sequentially, it rose 39.7% from the prior quarter.

Context

  • Net income amounted to 14.3% of revenue in FY2025, down 16.3 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 2 analysts of $195.32M (+216.9%) for the fiscal year ending Dec 2026, a step up from the -61.2% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$49.3M+39.7% QoQ
Last fiscal yearDec 2025
-$167.1M-61.2% YoY
LTMSep 2026
$59.8M+190.7% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.3%+136.0%+122.7 pp
1 year-61.2%+216.9%+278.1 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(167.1M) USD
Year-over-year change
+61.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +190.7% is the 5th highest of 10, against a peer median of +128.1%.
  • Net income amounts to 5.3% of revenue for NGVT, versus a peer median of 6.6%.
NGVT Competitors
Net Income for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMCFMC CorporationLTM Mar 2026$2.46B USD-740.1%—71.6%
ASHAshland Inc.LTM Jun 2026$683M USD-18.4%—37.1%
CCThe Chemours CompanyLTM Jun 2026$319M USD-22.4%—5.5%
SKESkeena Resources LimitedLTM Sep 2026CA$263.95M CAD+128.1%+27.1%—
MTXMinerals Technologies Inc.LTM Apr 2026$161.7M USD+785.2%—7.6%
OLNOlin CorporationLTM Jun 2026$138.1M USD+757.8%—2.1%
IOSPInnospec Inc.LTM Jun 2026$122.3M USD+533.7%-4.3%6.6%
KWRQuaker Chemical CorporationLTM Sep 2026$97.28M USD+1184.4%-46.7%4.8%
ELVRElevra Lithium LimitedFY2025A$62.45M AUD——30.1%
NGVTIngevity CorporationLTM Sep 2026$59.8M USD+190.7%—5.3%
AAUCAllied Gold CorporationLTM Jun 2026$39.09M USD-64.7%-14.0%2.6%
Peer median (excluding NGVT) —+128.1%-9.2%6.6%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.